Antimalarial agents: closing the gate on Toll-like receptors?
Lafyatis
Robert
R
York
Michael
M
Marshak-Rothstein
Ann
A
D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use*; D018450:Disease Progression; D006801:Humans; D006886:Hydroxychloroquine / Q000097:blood; D016898:Interferon-alpha / Q000097:blood / Q000502:physiology; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D051193:Toll-Like Receptors / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000502:physiology
D000962:Antimalarials; D016898:Interferon-alpha; D051193:Toll-Like Receptors; D006886:Hydroxychloroquine